FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890327513> ?p ?o ?g. }

• W2890327513 endingPage "17020" @default.
• W2890327513 startingPage "17008" @default.
• W2890327513 abstract "Vascular calcification (or mineralization) is a common complication of chronic kidney disease (CKD) and is closely associated with increased mortality and morbidity rates. We recently reported that activation of the activating transcription factor 4 (ATF4) pathway through the saturated fatty acid (SFA)-induced endoplasmic reticulum (ER) stress response plays a causative role in CKD-associated vascular calcification. Here, using mouse models of CKD, we 1) studied the contribution of the proapoptotic transcription factor CCAAT enhancer–binding protein homologous protein (CHOP) to CKD-dependent medial calcification, and 2) we identified an additional regulator of ER stress–mediated CHOP expression. Transgenic mice having smooth muscle cell (SMC)–specific CHOP expression developed severe vascular apoptosis and medial calcification under CKD. Screening of a protein kinase inhibitor library identified 16 compounds, including seven cyclin-dependent kinase (CDK) inhibitors, that significantly suppressed CHOP induction during ER stress. Moreover, selective CDK9 inhibitors and CRISPR/Cas9-mediated CDK9 reduction blocked SFA-mediated induction of CHOP expression, whereas inhibitors of other CDK isoforms did not. Cyclin T1 knockout inhibited SFA-mediated induction of CHOP and mineralization, whereas deletion of cyclin T2 and cyclin K promoted CHOP expression levels and mineralization. Of note, the CDK9–cyclin T1 complex directly phosphorylated and activated ATF4. These results demonstrate that the CDK9–cyclin T1 and CDK9–cyclin T2/K complexes have opposing roles in CHOP expression and CKD-induced vascular calcification. They further reveal that the CDK9–cyclin T1 complex mediates vascular calcification through CHOP induction and phosphorylation-mediated ATF4 activation. Vascular calcification (or mineralization) is a common complication of chronic kidney disease (CKD) and is closely associated with increased mortality and morbidity rates. We recently reported that activation of the activating transcription factor 4 (ATF4) pathway through the saturated fatty acid (SFA)-induced endoplasmic reticulum (ER) stress response plays a causative role in CKD-associated vascular calcification. Here, using mouse models of CKD, we 1) studied the contribution of the proapoptotic transcription factor CCAAT enhancer–binding protein homologous protein (CHOP) to CKD-dependent medial calcification, and 2) we identified an additional regulator of ER stress–mediated CHOP expression. Transgenic mice having smooth muscle cell (SMC)–specific CHOP expression developed severe vascular apoptosis and medial calcification under CKD. Screening of a protein kinase inhibitor library identified 16 compounds, including seven cyclin-dependent kinase (CDK) inhibitors, that significantly suppressed CHOP induction during ER stress. Moreover, selective CDK9 inhibitors and CRISPR/Cas9-mediated CDK9 reduction blocked SFA-mediated induction of CHOP expression, whereas inhibitors of other CDK isoforms did not. Cyclin T1 knockout inhibited SFA-mediated induction of CHOP and mineralization, whereas deletion of cyclin T2 and cyclin K promoted CHOP expression levels and mineralization. Of note, the CDK9–cyclin T1 complex directly phosphorylated and activated ATF4. These results demonstrate that the CDK9–cyclin T1 and CDK9–cyclin T2/K complexes have opposing roles in CHOP expression and CKD-induced vascular calcification. They further reveal that the CDK9–cyclin T1 complex mediates vascular calcification through CHOP induction and phosphorylation-mediated ATF4 activation." @default.
• W2890327513 created "2018-09-27" @default.
• W2890327513 creator A5023340444 @default.
• W2890327513 creator A5027334267 @default.
• W2890327513 creator A5032236530 @default.
• W2890327513 creator A5034499882 @default.
• W2890327513 creator A5051013447 @default.
• W2890327513 creator A5054482058 @default.
• W2890327513 creator A5060143286 @default.
• W2890327513 creator A5083433627 @default.
• W2890327513 creator A5083816730 @default.
• W2890327513 date "2018-11-01" @default.
• W2890327513 modified "2023-10-17" @default.
• W2890327513 title "The CDK9–cyclin T1 complex mediates saturated fatty acid–induced vascular calcification by inducing expression of the transcription factor CHOP" @default.
• W2890327513 cites W1481179850 @default.
• W2890327513 cites W1495011086 @default.
• W2890327513 cites W1532231795 @default.
• W2890327513 cites W1970728706 @default.
• W2890327513 cites W1971285494 @default.
• W2890327513 cites W1972674519 @default.
• W2890327513 cites W1973000551 @default.
• W2890327513 cites W1975457924 @default.
• W2890327513 cites W1977603207 @default.
• W2890327513 cites W1981113072 @default.
• W2890327513 cites W1985139403 @default.
• W2890327513 cites W1989382448 @default.
• W2890327513 cites W1990125930 @default.
• W2890327513 cites W1992636607 @default.
• W2890327513 cites W2001399725 @default.
• W2890327513 cites W2008949718 @default.
• W2890327513 cites W2019832656 @default.
• W2890327513 cites W2025511820 @default.
• W2890327513 cites W2026540040 @default.
• W2890327513 cites W2027966439 @default.
• W2890327513 cites W2029682503 @default.
• W2890327513 cites W2032896143 @default.
• W2890327513 cites W2047723003 @default.
• W2890327513 cites W2049972435 @default.
• W2890327513 cites W2057228860 @default.
• W2890327513 cites W2059083151 @default.
• W2890327513 cites W2074974255 @default.
• W2890327513 cites W2075152619 @default.
• W2890327513 cites W2077881872 @default.
• W2890327513 cites W2079436570 @default.
• W2890327513 cites W2079489048 @default.
• W2890327513 cites W2081567150 @default.
• W2890327513 cites W2081756215 @default.
• W2890327513 cites W2085907524 @default.
• W2890327513 cites W2089353165 @default.
• W2890327513 cites W2098291651 @default.
• W2890327513 cites W2098317549 @default.
• W2890327513 cites W2100321761 @default.
• W2890327513 cites W2102334161 @default.
• W2890327513 cites W2103608656 @default.
• W2890327513 cites W2108116509 @default.
• W2890327513 cites W2117770733 @default.
• W2890327513 cites W2124591820 @default.
• W2890327513 cites W2129503078 @default.
• W2890327513 cites W2134334713 @default.
• W2890327513 cites W2135681201 @default.
• W2890327513 cites W2141321399 @default.
• W2890327513 cites W2146662079 @default.
• W2890327513 cites W2152713621 @default.
• W2890327513 cites W2157224349 @default.
• W2890327513 cites W2167411243 @default.
• W2890327513 cites W2547347902 @default.
• W2890327513 cites W2593538080 @default.
• W2890327513 cites W3022823009 @default.
• W2890327513 doi "https://doi.org/10.1074/jbc.ra118.004706" @default.
• W2890327513 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6222109" @default.
• W2890327513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30209133" @default.
• W2890327513 hasPublicationYear "2018" @default.
• W2890327513 type Work @default.
• W2890327513 sameAs 2890327513 @default.
• W2890327513 citedByCount "23" @default.
• W2890327513 countsByYear W28903275132019 @default.
• W2890327513 countsByYear W28903275132020 @default.
• W2890327513 countsByYear W28903275132021 @default.
• W2890327513 countsByYear W28903275132022 @default.
• W2890327513 countsByYear W28903275132023 @default.
• W2890327513 crossrefType "journal-article" @default.
• W2890327513 hasAuthorship W2890327513A5023340444 @default.
• W2890327513 hasAuthorship W2890327513A5027334267 @default.
• W2890327513 hasAuthorship W2890327513A5032236530 @default.
• W2890327513 hasAuthorship W2890327513A5034499882 @default.
• W2890327513 hasAuthorship W2890327513A5051013447 @default.
• W2890327513 hasAuthorship W2890327513A5054482058 @default.
• W2890327513 hasAuthorship W2890327513A5060143286 @default.
• W2890327513 hasAuthorship W2890327513A5083433627 @default.
• W2890327513 hasAuthorship W2890327513A5083816730 @default.
• W2890327513 hasBestOaLocation W28903275131 @default.
• W2890327513 hasConcept C11882975 @default.
• W2890327513 hasConcept C124320809 @default.
• W2890327513 hasConcept C139447449 @default.
• W2890327513 hasConcept C158617107 @default.
• W2890327513 hasConcept C16438837 @default.
• W2890327513 hasConcept C184235292 @default.
• W2890327513 hasConcept C185592680 @default.

• next